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Actin cytoskeletonThe LGI1 gene suppresses invasion in glioma cells and predisposes to epilepsy. In a gene expression array
comparison between parental cells and T98G cell clones forced to express LGI1, we demonstrate that the
canonical axon guidance pathway is the most signiﬁcantly affected. In particular, aspects of axon guidance
that involve reorganization of the actin cytoskeleton, which is also involved in cell movement and invasion,
were affected. Analysis of actin ﬁber organization using ﬂuorescence microscopy demonstrated that different
T98G cell clones expressing the exogenous LGI1 gene show high levels of stress ﬁbers compared with
controls. Since stress ﬁber formation is associated with loss of cell mobility, we used scratch wound assays to
demonstrate that LGI1-expressing clones show a signiﬁcant reduction in cell mobility. LGI1 reexpression also
resulted in loss of the PDGFRA and EGFR proteins, suggesting a rapid turnover of these receptors despite
increased mRNA levels for PDGFRA. LGI1 suppression of invasion is associated with loss of ERK/MAPK1
activation. LGI1 is a secreted protein, and when the culture supernatant from cells expressing FLAG- and
GFP-tagged proteins were applied to parental T98G cells, ERK/MAPK1 phosphorylation and cell mobility was
suppressed, demonstrating that the LGI1 protein acts as a suppressive agent for cell movement in this assay.
These observations support a previous suggestion that LGI1 can reduce cellular invasion in in vitro assays
and, as a secreted agent, may be developed as a means of treating metastatic cancer. In addition, this
observation provides a mechanistic link for LGI1's common role in metastasis and epilepsy development.
© 2009 Elsevier Inc. All rights reserved.Introduction
The LGI1 gene was originally isolated through its association with
a chromosome translocation breakpoint in a glioma cell line [1] and
has since been shown to have a regulatory function in the suppression
of cell migration and invasion of the cells through down-regulation of
the MEK/ERK (MAPK1) pathway [2,3]. Absence of LGI1 expression
was related to tumor progression [1] and reexpression of LGI1 in null
cells resulted in almost complete suppression of invasion in vitro and
loss of the ability to grow under anchorage independent conditions
[2]. In neuroblastoma cells, reexpression of LGI1 results in apoptosis
[4]. By linkage studies, LGI1 was associated with an epilepsy
phenotype [5] in families showing a rare form of autosomal dominant
partial epilepsy with auditory features (ADPEAF). Genetic analysis of
affected individuals in these hereditary cases demonstrated muta-
tions in LGI1 [6] and these observations have been extended in
subsequent studies [7,8].Roswell Park Cancer Institute,
osa Road, Madison, WI 53719,
ll rights reserved.The question that arises from these different observations is how
can the same gene that predisposes to a neuronal-related abnormality
as a result of haploinsufﬁciency in humans also suppress the invasion
phenotype in glioma cells. Since neuronal cells and glia are derived
from a common precursor neuroepithelial stem cell, and even though
these are end-stage differentiated cells that have very distinct
functions, it is possible that both cell types have adapted similar
genetic pathways to execute some common cellular functions.
Since LGI1 appears to function in different, but related ways in
different cell types, there have been conﬂicting interpretations about
the relative role of LGI1 in different cell contexts. The role of LGI1 in
brain development awaits the development of a knockout mouse,
since its function in post-mitotic cells is hard to establish in vitro. In
contrast, the demonstration that reexpression of LGI1 in glioma cells
null for endogenous activity has a profound effect on the invasion
phenotype of these cells [2] provides an opportunity to investigate the
consequences of reexpressing this gene on the cellular gene
expression proﬁle. LGI1 is a secreted protein [9,10] which has recently
been shown to bind on the surface of neuronal cells and affect sodium
channel functioning [11]. LGI1 is found in a protein complex with the
ADAM22/23 cell adhesion/receptor protein [12], which when
mutated results in seizures. Since the secreted LGI1 protein may
have signaling capabilities in glial cells that derive from the docking of
this protein with partners at the cell membrane, we undertook a gene
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compare cells that express LGI1 with those that do not. Pathways
analysis identiﬁed a canonical pathway involving axon guidance, as it
relates to actin cytoskeleton reorganization, that is signiﬁcantly
affected by LGI1 expression. These observations provide an important
link between the involvement of these pathways in glial cell types in
the context of cancer metastasis. Since actin cytoskeleton reorganiza-
tion is also involved in cell movement, we further demonstrate that
glioma cells expressing exogenous LGI1 show increased stress ﬁber
formation and marked reduction in cell mobility. The same pheno-




RNA was prepared from cell lines grown in DMEM, supplemented
with 10% fetal bovine serum as described previously [13] and used to
generate cRNA probes for hybridization to the Affymetrix U133Plus2
humangene expression arrays using standardprocedures [14]. RT-PCR
analysis was performed using 2 μg of cDNA from both vector control
and LGI1 expressing cells and semi-quantitative PCR was performed
following the generation of cDNA from cell line-derived RNA as
described previously [15]. Normal human astrocytes were obtained
from Cambrex–Clonetics (New Brunswick, NJ) and maintained in the
custom formulated medium provided by the manufacturer.
Quality control of the raw .CEL intensityﬁleswas assessed using the
QC statistics associated with the ‘simpleaffy’ and ‘affyPLM’ R packages
which include MA-plots of quantile-normalized signal, RNA degrada-
tion plots, probe level model (PLM) residuals, relative log expression
(RLE), and normalized unscaled standard error (NUSE) and median
absolute deviation (MAD). In addition, spatial biases were explored
using the SmudgeMiner library. All of the arrays passed these quality
measures and principle components analysis (PCA) demonstrated no
signiﬁcant variation due to technical aspects of the analysis.
Normalization, background subtraction and summarization of
probe intensities were processed using an adaptation of Robust
Multi-Chip Average (RMA) [16], with speciﬁc correction for G–C
biases known as GC-RMA [17]. The quantile-normalized PM values
were then log transformed and all the probes in a set representing
speciﬁc genes were summarized using Tukey's median polishing
procedure.
After performing extensive pre-processing using R statistical
software, additional ﬁltering steps were undertaken using the MAS5
‘absent,’ ‘present’ and ‘marginal’ detection calls. Within a group of
samples that pass quality control criteria, probe sets which show
‘absent’ for all samples were ﬁltered out to avoid excessive false
discoveries. The ﬁltered data set was then imported into statistical
packages from Partek Genomics for visualization. PCA, which is useful
in reducing the dimensions of microarray data, was used to examine
whether clusters could be explained by the ﬁrst few principle
components, which is ordered by the eigen values of the covariance
matrix. Since dimensionality reduction using PCA has been shown to
degrade cluster quality in certain instances [18], unsupervised
hierarchal clustering using the Pearson correlation coefﬁcient as a
distance metric is performed as a comparison to the clustering
structure provided by PCA. Since concordance of the clustering
structure was observed between the two dimensionality-reduction
procedures, n-way ANOVA analysis was performed comparing the
various clusters. Generally, a group difference of 2-fold between the
clusters and a p-value of 0.05 based on the t-statistic after adjustment
for multiplicity by way of the Bonferroni (FWER) or Benjamini–
Hochberg (FDR) correction was considered signiﬁcant.
To deﬁne how the individual regulated genes interact as parts of
complexes, pathways and biological networks we used the IngenuityPathway Analysis software which computes a score for each network
according to the ﬁt of the network, using a cut-off score of 1.3 to
identify gene networks signiﬁcantly affected by reexpression of LGI1.
This score indicates that there is a 5% chance that the genes are in a
network due to random chance alone.
Wound healing assay
The wound-healing assay is a simple, inexpensive method to study
directional cell migration in vitro. In brief, cells were cultured in six
well plates to conﬂuency. Cultures were then washed once with PBS
and a linear scratch was created in the cell monolayer with a pipette
tip. After marking the position of the ‘wound,’ the cells were again
washed twice with PBS and fresh culture medium was added. Using
an inverted microscope (4× magniﬁcation) each wound was
photographed at time=0 and then again 24 h later. The relative
efﬁciency of wound closure was calculated using the ImageJ software
and then plotted using the GraphPad prism software. The wound
closure was deﬁned as the ratio of the extent of the remaining
wounded area relative to that of the initial area. To study the effect of
secreted LGI1 on wound closure supernatant from LGI1 secreting cells
was collected and concentrated using Amicon Millipore columns and
then added to the T98G cells immediately after the scratchwoundwas
made. After 24 h , these cell monolayers were again photographed and
the extent of wound closure was measured and compared to control
cells treated in the same way. Experiments were repeated at least
three times in six replicates.
Immunoﬂuorescence microscopy
Cells (105 cells/well) were grown in DMEM containing 10%
fetal bovine serum (FBS) on glass coverslips (22×22 mm) for 24 h.
Cells were then ﬁxed with 2% paraformaldehyde–PBS. Actin
ﬁlaments (F-actin) were stained with a 1: 500 anti-phalloidin-Texas
Red antibody in PBS (Molecular Probes, Eugene, OR). Fluorescent
images were captured using a Nikon TE2000-E inverted microscope
(Garden City, NY).
Western blot analysis
Cells were lysed in RIPA buffer containing protease and phospha-
tase inhibitors. Protein lysates (40 μg) were size fractionated on
polyacrylamide gels and Western blot analysis was performed using
total anti-PDGFR alpha and beta, and anti-EGFR antibodies (Santa
Cruz) at 1:1000 dilution. Protein detection was performed using
1:5000 anti-rabbit HRP secondary antibodies (Amersham) and
developed using ECL chemiluminescence reagent from NEN.
Results
Western blot assays demonstrated that all of the T98G clones
carrying LGI1 showed down-regulation of ERK phosphorylation
(activation) compared with the vector-only clones which showed
constitutional expression of activated ERK [3]. The profound effect
seen previously on cell invasion and growth in soft agar [2] was re-
conﬁrmed in these clones expressing LGI1. In the gene expression
array analysis we compared individually derived clones expressing
LGI1 or containing the empty pcDNA3 vector or LGI1 using Affymetrix
U133 Plus2 arrays, which contains N22,000 genes. Three indepen-
dently derived clones from each group were used in the comparison.
Processing of gene expression data
Quality control of the raw .CEL intensity ﬁles prior to preprocessing
was assessed using the ‘affyQCReport’ library in the R statistical
programming environment, which incorporates various additional
Table 1
Summary of the fold changes of the down-regulated and up-regulated genes of a representative sample of those showing the highest fold changes.
Probe ID Gene FC (decrease) Probe ID Gene FC (increase)
203324_s_at CAV2 − 388.941009 205767_at EREG 148.6190033
202016_at MEST −348.2319946 1552971_at SGCZ 100.3779984
204620_s_at CSPG2 − 124.1279984 210432_s_at SCN3A 83.24169922
225275_at EDIL3 − 71.36370087 203131_at PDGFRA 75.53769684
219837_s_at CYTL1 − 61.41600037 212865_s_at COL14A1 74.65879822
213416_at ITGA4 − 60.1966019 204818_at HSD17B2 67.50180054
212977_at CXCR7 − 59.62039948 1566968_at SPRY4 61.99990082
213194_at ROBO1 − 50.9077988 202546_at VAMP8 61.45629883
203184_at FBN2 − 49.20669937 221911_at ETV1 49.39530182
210511_s_at INHBA − 43.93939972 227276_at PLXDC2 31.3939991
215646_s_at VCAN − 41.77500153 227059_at GPC6 31.04870033
243366_s_at CERKL − 30.16259956 202668_at EFNB2 27.7052002
236044_at PPAPDC1A − 30.13509941 206295_at IL18 24.93589973
236824_at TMEM132B − 24.02289963 230645_at FRMD3 24.36370087
229947_at PI15 − 23.96629906 202291_s_at MGP 21.44120026
227261_at KLF12 − 22.36009979 210517_s_at AKAP12 21.32439995
204105_s_at NRCAM − 22.13750076 219230_at TMEM100 19.09819984
201631_s_at IER3 − 19.18370056 225207_at PDK4 19.03770065
212942_s_at KIAA1199 − 18.66180038 1554997_a_at PTGS2 18.06200027
204364_s_at REEP1 − 18.09609985 1552511_a_at CPA6 17.88500023
206155_at ABCC2 − 17.21590042 213049_at RALGAPA1 17.51539993
226677_at ZNF521 − 17.16799927 219014_at PLAC8 17.46640015
218723_s_at C213orf15 − 16.99559975 205650_s_at FGA 15.91399956
205828_at MMP3 − 15.7476997 219033_at PARP8 15.0394001
209875_s_at SPP1 − 15.6086998 227399_at VGLL3 14.07759953
209031_at CADM1 − 15.57870007 209955_s_at FAP 13.73390007
211571_s_at CSPG2 − 15.36250019 218451_at CDCP1 13.25669956
227197_at SGEF − 13.90799999 203151_at MAP1A 13.2112999
204042_at WAVE3 − 13.5626001 201042_at TGM2 12.84910011
219310_at TMEM90B − 12.8920002 220794_at GREM2 12.27639961
223340_at ATL1 − 12.44659996 220615_s_at FAR2 11.30560017
235874_at PRSS35 − 12.2407999 211990_at HLA-DPA1 11.09770012
218694_at ARMCX1 − 12.13899994 219478_at WFDC1 10.97350025
225342_at AK3L1 − 11.80860043 202409_at IGF2 10.84459972
213170_at GPX7 − 11.55970001 228575_at IL20RB 10.70629978
227224_at RALGPS2 − 6.732211 239907_at KIAA1026 10.64669991
203666_s_at CXCL12 − 4.897001 205870_at BDKRB2 10.43519974
205405_at SEMA5A − 3.26049 201739_at SGK1 10.07999992
206805_at SEMA3A − 2.114749908 223618_at FMN2 10.03419971
Genes germane to the discussion in this report are highlighted in bold.
Fig. 1. Semi-quantitative (25-cycle) analysis of expression levels for genes identiﬁed
using the U133Plus2 array analysis as up-regulated or down-regulated (see text). Lanes
1–3 represent individual clones from T98G carrying the empty pcDNA3 vector, and
lanes 4–6 represent different individual clones expressing the exogenous LGI1 gene.
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This analysis revealed no signiﬁcant quality control issues associated
with any of the hybridization reactions in this experiment (data not
shown).
After standard data preprocessing (see Materials and methods),
ﬁltering was performed, and principal components analysis (PCA)
demonstrated that the only factor that was signiﬁcantly associated
with the largest separation of the biological data was the presence of
LGI1 expression. Using one-way ANOVA, incorporating Benjamini–
Hochberg multiplicity correction, 1461 high quality probesets (FDR
DEGs) demonstrated at least a 2-fold differential expression with an
FDR of 0.05 in a comparison between three independently isolated
LGI1 expressing T98G clones and three parental T98G cell clones
expressing the empty vector. The deﬁnition of differential expression
in this analysis followed very strict criteria where, only if the change
in gene expression levels was observed in all three clones, in both the
test and control samples, was the gene included in the ﬁnal analysis.
Gene expression data were analyzed as described in Materials and
methods, identifying 738 of the 57,000 probe sets with a greater than
2-fold increase in expression levels and 724 probe sets showing a
greater than 2-fold decrease in expression levels. Because of the
redundancy on the U133Plus2 arrays, this corresponds to 525 genes
with N2-fold decreases and 560 with N2-fold increases of the ∼22,000
discrete genes on the array. Selected examples, including those
relevant to the following discussion, are shown in Table 1. Expression
levels were deﬁned relative to those seen in normal cultures of
primary astrocytes, which we felt was the closest available cell type oforigin for glial cells. In the ﬁnal analysis, however, the comparisonwas
essentially between T98G parental cells and T98G cells expressing
exogenous LGI1, which allowed us to assess the inﬂuence of LGI1 on
overall cellular gene expression levels.
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Fig. 3. Fluorescence microscopic analysis of parental T98G cells and cells expressing an
exogenous LGI1 gene (TF1) shows increased stress ﬁber formation in the LGI1-
expressing cells (A–C). Analysis of the EGF receptor (D) shows typical membrane
localization (red) in the parental T98G cells but almost complete loss of protein in the
LGI1-expressing cells.
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we selected representatives for veriﬁcation using semi-quantitative
RT-PCR analysis (Fig. 1), primarily to demonstrate that the expression
changes seen on the array were not due to unforeseen artifacts. The
up-regulated genes that were selected were GPC6, PDGFRA, SCN3A
and VAMP8. Down-regulated genes selected were CAV2, ITGA4,
RALGPS2, ROBO1 and WAVE3. In all cases, the array-generated
suggestion of up- or down-regulation was conﬁrmed in this analysis
(Fig. 1).
The FDR DEGs were then submitted to the Ingenuity Pathways
Analysis (IPA) workﬂow to potentially identify pathways and
interaction networks that are overrepresented in the FDR DEG
group with high statistical conﬁdence and which therefore provide a
better understanding of the consequences of the experimental
manipulation. This software describes functional relationships
between gene products based on published interactions that have
been manually curated. Using IPA, the FDR DEGs (Fig. 2) demon-
strated that the Axonal Guidance Signaling pathway was statistically
the most overrepresented pathway, with a p-value of b0.00001,
where approximately 10% of the genes in the curated axonal
guidance signaling pathway were shown to be differentially
expressed. Several other well characterized pathways were also
shown to be overrepresented including IGF-1, NF-κB and the ERK/
MAPK signaling pathways but did not show statistical signiﬁcance
(data not shown).
The canonical axon guidance pathway shares one essential feature
with cancer cell movement and invasion in that they both require
reorganization of the actin cytoskeleton. We have previously demon-
strated that reexpression of LGI1 in glioma cells suppresses invasion
through a basement membrane structure in vitro [2] through down-
regulation of MMPs. To determine whether the loss of movement is
related to formation of actin stress ﬁbers, a common phenotype
associatedwith loss of movement, we compared phalloidin staining in
parental T98G cells with those forced to reexpress LGI1. As shown in
Fig. 3 the LGI1-expressing cells clearly show signiﬁcantly increased
levels of stress ﬁbers. To determine whether this phenotype is related
to loss of cell movement, we subjected T98G cells to scratch wound
assays. Over a 24-h period, parental T98G cells almost completely
closed the gap created in the cell monolayer (Fig. 4). This response
could not be accounted for by cell proliferation, since T98G cells have a
cycle time of ∼20 h [2]. T98G cells expressing an exogenous LGI1 gene,
on the other hand, were relatively unable (b40%) to signiﬁcantly close
the wound in this assay (Fig. 4) demonstrating a suppression of cell
motility.
LGI1 is a secreted protein [9,10,19]. To further delineate whether
the LGI1 protein is responsible for the observed loss of motility, we
harvested the supernatant from the T98G clones expressing exogen-
ous FLAG-tagged LGI1 which was secreted into the medium. This
supernatant was then concentrated and applied to T98G cell
monolayers in which a scratch wound had been created. Over a 24-
h period, although parental cells again close the wound when
incubated in normal medium, the cells treated with LGI1-containing
supernatant were unable to signiﬁcantly close the wound (Fig. 4).
Supernatants from T98G parental cells were similarly collected and
applied to fresh cultures and showed no effect on closure of the
wound. These results demonstrate that the effect on the movement
phenotype is due to the secreted LGI1 protein, since supernatants
from parental T98G cells when applied to the same cells in parallel did
not have the same effect. In addition, we have generated 293 cells that
constitutively express, and secrete, a GFP-tagged LGI1 protein [10].
Application of supernatants from these cells also suppressed wound
closure, although supernatant from 293 parental cells did not,Fig. 2. Summary analysis of the axon guidance pathway identiﬁed using Ingenuity Pathway
comparison between T98G cells which do and do not express LGI1.demonstrating that the speciﬁc tags do not affect the function of
this protein in this respect (data not shown). To relate this loss of
wound closure to ERK activity, we analyzed phospho-ERK levels in
the T98G cells which were previously shown to be reduced below
detectable levels by Western blotting in T98G-LGI1 cells [3]. As
shown in Fig. 5, ERK1/2 activity in the cells treated with the LGI1-
containing supernatants essentially show undetectable levels of ERK
phosphorylation.
LGI1 expression reduces growth factor receptor protein levels
The platelet derived growth factor receptor alpha (PDGFRA) gene
was one of the most highly up-regulated genes seen in this gene
expression analysis (Table 1). This observation was conﬁrmed using
RT-PCR (Fig. 1). Western blot analysis for PDGFRA using protein
lysates from T98G parental and LGI1 expressing cells, however,
demonstrated that levels of the receptor protein were reduced to
below detectable levels. To determine whether a similar effect was
seen for the epidermal growth factor receptor (EGFR), which was
also shown to be over-expressed in T98G parental cells (Fig. 5) and
related to ERK inactivation, we used confocal microscopy to studys Analysis showing up-regulated genes (red) and down-regulated genes (green) in a
Fig. 4. Scratch wound assays for parental T98G cells (above) and LGI1-expressing cells (TF1-below). In both cases the images on the left were obtained immediately after the wound
was created and the images on the right were obtained 24 h later. Quantitation (lower graph) of the degree of wound closure (see Materials and methods) demonstrates that while
the parental (T98G) cells can almost completely close the wound, the LGI1-expressing cells (TF1) show a reduced capacity. When supernatants from parental T98G cells were
applied to fresh T98G cells, using a 500-fold (S20P) or 1000-fold (S10P) concentration, the parental T98G cells show no signiﬁcant difference in their ability to close the wound after
24 h. In contrast, when the supernatants from T98G cells expressing the LGI1-ﬂag protein were added to fresh cultures of T98G cells, also with 500-fold (S20F) and 1000-fold (S10F)
concentrations, wound closure was largely inhibited.
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in Fig. 3, the typical EGFR membrane localization seen in the
parental cells was lost in the LGI1 expressing cells. Western blot
analysis further demonstrated that, as with PDGFRA, protein levels
were below the limits of detection in LGI1-expressing T98G cells
(Fig. 5).Fig. 5. Western blot analysis of phospho-ERK protein levels (above) demonstrate
absence of the activated proteins in cells expressing exogenous LGI1 (TF1) compared
with the parental T98G cells. When supernatants from either LGI1-ﬂag expressing
cells (STF1) of GFP-LGI1 expressing cells (SLGFP) are added to parental T98G cells,
phospho-ERK protein levels are similarly reduced. Analysis of EGFR and PDGFRA
protein levels in three clones (TF1, TF3 and TF4) of T98G cells expressing the LGI1-Flag
protein shows almost undetectable levels of the receptor proteins compared with the
parental T98G cells.Discussion
One of the conundrums presently surrounding the function of LGI1
derives from the observations that its haploinsufﬁciency in humans
leads to a predisposition to epilepsy [6] and its forced reexpression in
glioma cells inhibits cell migration and invasion [2]. We have shown
in this study that many genes that are known to be associated with
pathways that have been implicated in the process of axon guidance,
and which lead to axon outgrowth, repulsion, attraction and neurite
retraction, as well as cone collapse in a neuronal cell context,
primarily through actin reorganization, are also dysregulated in
glioma cells forced to express LGI1. Thus, it appears that the same
pathways are affected, although the phenotypic consequences are
different depending on the cell context. This observation may not be
surprising since glia and neurons are derived from the same
neuroepithelial stem cell. In fact, the process of axon guidance and
neuronal migration has been shown to be associated withmany of the
same genes that are implicated in glioma cell invasion andmetastasis.
The matrix metalloproteinases, such as MMP3 for example, were
shown to be inactivated in the presence of LGI1 [3], which was
presumed to be related to the loss of invasion in these cells compared
to the parental glioma cells that did not express LGI1. MMPs also
perform essential functions during neuroplasticity in both the
developing and adult nervous systems, including guidance and
establishment of axonal terminal ﬁelds [20], and inhibition of MMP
activity prevents aspects of the deafferentation/sprouting cycle.
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[6] S. Kalachikov, O. Evgrafov, B. Ross, M. Winawer, C. Barker-Cummings, F. Martinelli
Boneschi, C. Choi, P. Morozov, K. Das, E. Teplitskaya, et al., Mutations in LGI1 causeMMP3, in particular, has been implicated in cortical axon outgrowth
and optimal axon extension [21]. This process is related to
semaphorin 3C-dependent chemo-attraction of cortical axons which
is inhibitory to the process. In the gene expression studies presented
here, semaphorin 3A and 5A were down-regulated in the presence of
LGI1 expression (Table 1). High levels of expression of SEMA5A have
been associated with aggressiveness in cancer cells [22], and support
the idea that its down-regulation in the presence of LGI1 may be
related to the loss of invasiveness in these cells. The connection
between axon outgrowth and metastasis was also demonstrated for
the Syntenin gene in melanoma [23]. Syntenin interacts with Unc51.1,
a serine/thronine kinase that promotes neurite extension in neurons
[23]. Overexpression of Syntenin in melanoma cells prevented
migration, invasion and anchorage independent growth [24] in a
similar way that LGI1 suppressed these phenotypes in glioma cells [3].
Another strong link between forced overexpression of LGI1 in
glioma cells and the axon guidance pathway is seen in the down-
regulation of ROBO1, the receptor for the SLIT protein which drives
axon guidance. Although these two proteins are distinct, the leucine
rich domain in the SLIT and LGI1 proteins is highly homologous [1],
potentially suggesting a related function for these proteins. ROBO1 is
an axon guidance receptor that regulates midline crossing [25] and
affects neuronal precursor migration. Recently ROBO1 has been
suggested to participate in glioma cell guidance within the brain
[26] and possibly facilitates metastasis of breast cancer cells to the
brain, through the action of chemo-attractants in the CXCR/CXCL
chemokine receptor/ligand family [27]. CXCR7 and CXCL12 were
down-regulated in cells expressing LGI1 (Table 1).
WAVE3, also known asWASF3, has also been implicated in invasion
and metastasis [28,29]. High levels of this protein were seen in
advanced stage breast cancer and knockdown using siRNA resulted in
loss of in vitro invasion and metastasis in vivo, which correlated with
reduced lamellipodia formation [30,31]. Up-regulation of WAVE3 is
positively correlated with increased cell movement and invasion,
through actin cytoskeleton reorganization. In this series of experi-
ments, expression of LGI1 resulted in down-regulation of WAVE3
which is consistent with the suppression of movement in these cells.
Recently, it was demonstrated that ROBO1 is essential for ﬁlopodia
formation in endothelial and down-regulation in these cells sup-
presses cell migration [32]. These observations are consistent with a
role for LGI1 in suppressing cell movement in glioma cells through
down-regulation of ROBO1.
Our detailed analysis of gene expression changes in glioma cells,
that show inhibition of invasion as a result of over-expression of LGI1,
demonstrates major reorganization of the expression of genes
involved in neuronal migration and axon guidance, and many of
these genes have also been implicated in cancer cell metastasis and
invasion. These observations support the idea that LGI1, in different
cell contexts, can profoundly inﬂuence both processes [33]. It should
be noted that the LGI1-relatedmechanisms that predispose to epilepsy
are only just beginning to be understood. Recent studies have
demonstrated an association with an ADAM22/23-containing com-
plex [11]. These members of a membrane associated family of
metalloproteinases are involved in signaling through glutamate
receptors and cell adhesionmolecules at synapse points. Interestingly,
the RALGPS2 gene whichwas down-regulated in LGI1 expressing cells
was shown to interact with the YWHAZ protein [34] which facilitates
surface expression of ADAM22 [35]. CAV2, which showed the highest
level of down-regulation, is also tied to receptor function through its
involvement with lipid raft function and internalization [36]. In
addition, the presence of LGI1 in a complex with the Kv1.1 (KCNA1)
voltage-gated potassium channel, and the demonstration that LGI1
can inhibit channel inactivation by cytoplasmic KCNAβ1 [12], points to
a role in neuronal function.Whether LGI1 has a role in development of
the brain cytoarchitecture, as might be expected from a function that
controls axon positioning, has not yet been speciﬁcally determined.Since loss of LGI1 in glioma cells promotes movement and invasion,
without signiﬁcantly affecting cell proliferation, it is possible that LGI1
is related speciﬁcally to the metastasis process by regulating cell
signaling pathways that are responsible for inﬂuencing actin cytoske-
leton reorganization as supported by the data presented here. As a
secreted protein, therefore, LGI1 has the potential to be developed as a
therapeutic agent that could control tumor cell invasion.
Addition of exogenous LGI1 protein to the parental T98G cells
resulted in down-regulation of the MAPK1 pathway and an inhibition
of wound closure (cell motility) compared to the parental T98G cells.
This phenotypic change suggested that a cell surface receptor might
be involved in mediating the LGI1 effect. The gene expression studies
demonstrated that PDGFRA transcription was up-regulated (possibly
as a result of increased expression of GLI1 seen on the expression
array, which is known to drive PDGFRA expression) but cells
expressing LGI1 showed drastically reduced levels of the receptor
protein. The same consequence was seen for the EGF receptor in T98G
cells expressing LGI1, suggesting that it may inﬂuence protein stability
for these two receptors. Interestingly, another human LRR protein,
LR1G1, was shown to bind with, and inhibit, the ERB2 member of the
EGFR family of receptor kinases by increasing internalization and
turnover rate of the receptor [37]. In these studies, lack of the receptor
proteins was demonstrated using Western blotting after introduction
of exogenous LR1G1. In addition, decorin, a secreted proteoglycan
which also carries an LRR motif, was shown to interact with EGFR in
Drosophila and was associated with a prolonged down-regulation of
the receptor, which resulted in inhibition of cellular growth by
increasing p21 [38]. Thus, there are now several examples where LRR-
containing proteins are associated with cell surface receptor stability
which results in reduced levels of these proteins and so may provide a
mechanism of down-regulating the MAPK1 pathway, and as a conse-
quence MMP3 production, which has shown to be an important
mediator of cell movement and metastasis [39,40].
Many genes known to be involved in axon guidance or other
speciﬁc neuronal functions are also expressed in glial cells as we have
shown here. Some of these genes appear to be dysregulated by forced
reexpression of LGI1 which accompanies loss of cellular invasion and
migration phenotypes. The analysis reported here, therefore, makes
the connection between genetic pathways that control normal
neuronal migration and glioma cell invasion. The exact role of LGI1
in neuronal cell development and function awaits the development of
the mutant null mouse for LGI1.
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